Sangamo Therapeutics (SGMO) Q1 2026 Earnings

25FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.14
-0.09
-0.05
-0

Details

Expected EPS
-0.01398
Actual EPS
N/A
Surprise EPS
0.01
Surprise Percent
+100%

Description

Sangamo Therapeutics (SGMO) will report earnings of for Q1 2026 on February 25, 2026.

0 Comments

Share your thoughts